222 related articles for article (PubMed ID: 25264402)
1. Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.
Painter CA; Stern LJ
Curr Top Biochem Res; 2011; 13(2):39-55. PubMed ID: 25264402
[TBL] [Abstract][Full Text] [Related]
2. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
3. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
Stratikos E; Wiley DC; Stern LJ
J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
[TBL] [Abstract][Full Text] [Related]
4. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
5. MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange.
Abualrous ET; Stolzenberg S; Sticht J; Wieczorek M; Roske Y; Günther M; Dähn S; Boesen BB; Calvo MM; Biese C; Kuppler F; Medina-García Á; Álvaro-Benito M; Höfer T; Noé F; Freund C
Nat Chem Biol; 2023 Oct; 19(10):1196-1204. PubMed ID: 37142807
[TBL] [Abstract][Full Text] [Related]
6. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
[TBL] [Abstract][Full Text] [Related]
7. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
Mosyak L; Zaller DM; Wiley DC
Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of peptide repertoire selection by HLA-DM.
Pos W; Sethi DK; Wucherpfennig KW
Trends Immunol; 2013 Oct; 34(10):495-501. PubMed ID: 23835076
[TBL] [Abstract][Full Text] [Related]
9. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
Painter CA; Negroni MP; Kellersberger KA; Zavala-Ruiz Z; Evans JE; Stern LJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19329-34. PubMed ID: 22084083
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
11. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
[TBL] [Abstract][Full Text] [Related]
12. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.
Wieczorek M; Abualrous ET; Sticht J; Álvaro-Benito M; Stolzenberg S; Noé F; Freund C
Front Immunol; 2017; 8():292. PubMed ID: 28367149
[TBL] [Abstract][Full Text] [Related]
13. What to do with HLA-DO/H-2O two decades later?
Welsh R; Song N; Sadegh-Nasseri S
Immunogenetics; 2019 Mar; 71(3):189-196. PubMed ID: 30683973
[TBL] [Abstract][Full Text] [Related]
14. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
15. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
16. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
17. HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1.
Narayan K; Su KW; Chou CL; Khoruzhenko S; Sadegh-Nasseri S
Mol Immunol; 2009 Sep; 46(15):3157-62. PubMed ID: 19647320
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
19. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
20. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.
vogt AB; Moldenhauer G; Hämmerling GJ; Kropshofer H
Immunol Lett; 1997 Jun; 57(1-3):209-11. PubMed ID: 9232453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
